Metronidazole foamAlternative Names: Metronidazole foam - Foamix
Latest Information Update: 08 Nov 2010
At a glance
- Originator Foamix
- Class Antibacterials; Antiprotozoals; Nitroimidazoles; Radiosensitisers; Small molecules
- Mechanism of Action DNA synthesis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Rosacea
Most Recent Events
- 08 Nov 2010 Discontinued - Preclinical for Rosacea in Israel (Topical)
- 02 Sep 2005 Preclinical trials in Rosacea in Israel (Topical)
- 02 Sep 2005 Metronidazole foam is available for licensing (http://www.foamix.co.il)